Methylenetetrahydrofolate reductase C677T polymorphism and the risks of polycystic ovary syndrome: an updated meta-analysis of 14 studies
Metrics: PDF 942 views | HTML 1599 views | ?
Lihong Wang1, Wenting Xu1, Caihong Wang1, Mengyu Tang2 and Yujia Zhou2
1From the Zhangjiagang Hospital of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China
2Zhangjiagang, The First Clinical College, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China
Lihong Wang, email: firstname.lastname@example.org
Keywords: PCOS, methylenetetrahydrofolate reductase, MTHFR, meta-analysis, polycystein
Received: February 23, 2017 Accepted: June 01, 2017 Published: June 14, 2017
Some studies have reported an association between the Methylenetetrahydrofolate reductase (MTHFR) C667T genetic variant and risk of polycystic ovary syndrome (PCOS), although the results remain controversial. A systematic search was conducted on PubMed, Web of Science, EMBASE, Ovid, Chinese National Knowledge Databases and WanFang databases with relevant keywords. Fourteen studies of sixteen distinct populations involving 1478 PCOS cases and used to conduct a meta-analysis. The T allele was not significantly associated with increased risk of PCOS [OR: 1.08; 95% CI: 0.96–1.21]. In the stratified analysis by ethnicity, the T allele significantly increases risks for the Asian [OR = 1.31; 95% CI: 1.09–1.58] population. No significant associations were detected for the Middle Eastern population [OR = 1.26; 95% CI: 0.96–1.67] and the T allele was found to be protective in the Caucasian population [OR = 0.82; 95% CI: 0.68–0.99]. In conclusion, this meta-analysis suggests that MTHFR C667T variant can increase, decrease, or have no effect on the risks of PCOS depending on the ethnicity.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.